[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Ionis Pharmaceuticals, Inc. Common Stock (IONS)
Ionis Pharmaceuticals (IONS) announces Q2 2025 earnings webcast on July 30th. Social media buzzes with positive sentiment driven by clinical trial results and partnerships.
About Ionis Pharmaceuticals, Inc. Common Stock
Ionis Pharmaceuticals, Inc. Common Stock (IONS) is a biotechnology company specializing in RNA-targeted therapeutics.
Ionis Pharmaceuticals, Inc. Common Stock uses the ticker $IONS for trading. Listed in the Stocks and category within the Healthcare sectors.
Insights #
- Ionis Pharmaceuticals, Inc. Common Stock (IONS) social dominance is up XXXXX% from the previous week.
- Ionis Pharmaceuticals, Inc. Common Stock (IONS) creators is up XXX% from the previous month.
- Ionis Pharmaceuticals, Inc. Common Stock (IONS) engagements is up XXX% from the previous week.
- Ionis Pharmaceuticals, Inc. Common Stock (IONS) mentions is up XXX% from the previous month.
Price: $XXXXX #
Price 24-Hour Chart Data
The stock price is experiencing sideways action due to a balance between positive clinical data and potential revenue, and downward pressure from competition and insider selling, although recent analyst upgrades provide upward momentum.
| 24-Hour | 7-Day | 30-Day |
|---|---|---|
| XXXX% | -XXX% | XXX% |
1-Year High: $XXXXX on 2024-07-26
1-Year Low: $XXXXX on 2025-04-08
AltRank: XXX #
AltRank 24-Hour Chart Data
Ionis Pharmaceuticals, Inc. Common Stock (IONS) is currently AltRank #866 based on combined combined social and market metrics
Daily Average: XXX
1 Week: XXXXX +784
1 Month: XXXXX +1,231
6 Months: XXXXX +1,012
1 Year: XXXXX +883
1-Year High: XXXXX on 2025-07-17
1-Year Low: XX on 2025-01-11
Galaxy Score: XXXXX #
Galaxy Score 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX -XX
1 Month: XX -XX
6 Months: XX -X
1 Year: XX -XX
1-Year High: XX on 2024-10-16
1-Year Low: XX on 2025-07-08
Engagements: XXXXXX #
Engagements 24-Hour Chart Data
Current Value: XXXXXX
Daily Average: XXXXXX
1 Week: XXXXXXX +204%
1 Month: XXXXXXX -XX%
6 Months: XXXXXXXXX +47%
1 Year: XXXXXXXXX +59%
1-Year High: XXXXXXX on 2025-02-19
1-Year Low: XXX on 2024-11-03
| Social Network | X | YouTube | |
|---|---|---|---|
| Engagements | XXXXXX | X | X |
Mentions: XX #
Mentions 24-Hour Chart Data
Current Value: XX
Daily Average: XX
1 Week: XXX +35%
1 Month: XXX +144%
6 Months: XXXXX +15%
1 Year: XXXXX +142%
1-Year High: XXX on 2024-12-22
1-Year Low: XX on 2024-09-29
| Social Network | X | YouTube | |
|---|---|---|---|
| Mentions | XXX | X | X |
Creators: XX #
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning Ionis Pharmaceuticals, Inc. Common Stock (IONS) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
1 Week: XXX +19%
1 Month: XXX +313%
6 Months: XXXXX +77%
1 Year: XXXXX +188%
1-Year High: XXX on 2025-06-27
1-Year Low: X on 2024-10-17
The most influential creators that mention Ionis Pharmaceuticals, Inc. Common Stock in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @ThePolarBearX | X | XXX | X | XXXXX |
Sentiment: XX% #
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -XX%
1 Month: XX% -X%
6 Months: XX% +30%
1 Year: XX% -XX%
1-Year High: XXX% on 2024-07-26
1-Year Low: XX% on 2025-01-08
Most Supportive Themes
- Positive Clinical Data and Partnerships: (45%) Positive clinical trial results, regulatory approvals, and analyst recognition drive positive sentiment, along with strategic partnerships.
Most Critical Themes
- Management Actions and Competitive Pressures: (5%) Concerns about management actions and competitive pressures affecting the stock.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXX | X% | XXXXXX | XX% | XX | X% |
| X | X% | X | X% | X | X% | |
| YouTube | X | X% | X | X% | X | X% |
| Total | XXX | X% | XXXXXX | XX% | XX | X% |
Social Dominance: XXXXXXX% #
Social Dominance 24-Hour Chart Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
1 Week: XXXXX% +0.0045%
1 Month: XXXXX% -XXXX%
6 Months: XXXXX% -XXXXX%
1 Year: XXXXX% -XXXXX%
1-Year High: XXXXX% on 2025-06-28
1-Year Low: XXXXXX% on 2024-10-17
Market Dominance: XXXXXXX% #
Market Dominance 24-Hour Chart Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2024-09-09
1-Year Low: XXXXXXX% on 2025-04-02
Market Cap: $XXXXXXXXXXXXX #
Market Cap 24-Hour Chart Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXX -$0.05%
1 Month: $XXXXXXXXXXXXX +$6.30%
6 Months: $XXXXXXXXXXXXX +$22%
1 Year: $XXXXXXXXXXXXX -$9.40%
1-Year High: $XXXXXXXXXXXXX on 2024-09-09
1-Year Low: $XXXXXXXXXXXXX on 2025-04-08
Top assets mentioned In the posts about Ionis Pharmaceuticals, Inc. Common Stock in the last XX hours
Bitcoin Incognito (XBI) SuperRare (RARE) Eli Lilly and Company (LLY) Biogen Inc (BIIB) Novartis AG (NVS) Alnylam Pharmaceuticals, Inc. (ALNY) Akropolis (AKRO) Eli Lilly and Company (LLY) Decentral Games ICE (ICE)
Top topics mentioned In the posts about Ionis Pharmaceuticals, Inc. Common Stock in the last XX hours
nvda, soun, hims, googl, amgn, $xbi, stocks, $rare, meta, manat, $ibb, smci, pltr, $lly, hood, hae, qqq, nxt, $qntm, $qure, amzn, $biib, investment, $nvs, rklb, vrtx, watchlist, coins ai, $alny, $rgnx, $cmps, akro, pfe, $tvtx, mira, $entb, $akro, $allo, stocks healthcare, eli lilly, $mgx, iv, spy, asts, stocks technology, mstr, ion, token, $ion, bmnr, nasdaq, $ice, asm, solv, nke, $nbix, $sgmo, $arwr, rna, ice open network, coins bsc, pdsb, aa, biogen inc, $gsk, pypl, $wdc, $adap, lidr, rblx, $kalv, $bcrx, stx, ice ice, hut, nrix, $bfly, $veev, $qsi, teva, spx, mrna, soc, papa johns, dnut, txt, $tars, sny, telo, coins layer 1, tak, deltarune, mpc, rivn, tko, fti, $thch, $vrna, arct, $kala
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Pdufa August XX. Switching to #Donidalsorsen brings fewer HAE swelling attacks: Study $ions $tak $bcrx $kalv $srpt $atxs $dyn $rna $stik $ibb $xbi"
@ArtsStocks on X 2025-07-24 20:01:05 UTC XXX followers, XXX engagements
"AI will be critical in medical space. $ARKG have them all so might as well buy this ETF. Should be $XX soon. $crsp $tem $twst $gh $rxrx $ntra $psnl $adpt $beam $cdna $sdgr $txg $ions $ntla $vcyt $ilmn $absi $arcr $nrix $amgn $pacb $mass $mass $qsi $veev $bfly @CathieDWood"
@ThePolarBearX on X 2025-07-24 15:56:15 UTC XXX followers, 1735 engagements
"$BGM Operating loss widened to $2.24M up XXX% YoY costs outpaced revenue gains. $PLTR $PFE $UPST $SOUN $AI $HIMS $ABCL $LLY $RXRX $GOOGL $IONS $TMO $NBIX"
@SusanRober84759 on X 2025-07-24 13:51:28 UTC XXX followers, XXX engagements
"H.C. Wainwright reiterated $KRRO Buy-$100 and said "Yesterday we hosted Korro Bio in the latest episode of our H.C. Wainwright @ Home series." $BEAM $WVE $PRQR $ARWR $IONS $ALNY H.C Wainwright added "We have three key takeaways from our discussion: (1) while DNA-editing approaches and exogenous protein therapies are alternative options to treat AATD RNA therapy is uniquely positioned as it is a highly-specific approach that harnesses the body's machinery to restore normal protein levels and address the disease in both the lung and liver; (2) KRRO-110's IV route of administration provides a"
@Quantumup1 on X 2025-07-24 12:22:13 UTC 3527 followers, 1787 engagements